Skip to content

Clinical efficacy and safety of acupuncture in improving anxiety and depression after interventional intervention of qi stasis and blood stasis coronary heart disease

Clinical efficacy and safety of acupuncture in improving anxiety and depression after interventional intervention of qi stasis and blood stasis coronary heart disease

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073124
Enrollment
Unknown
Registered
2023-07-03
Start date
2023-07-04
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Qi stasis coronary heart disease interventional postoperative anxiety and depression state

Interventions

Acupuncture group:Acupuncture
Sham acupuncture group:Sham acupuncture
Control group:Basic medicine treatment

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria of Western medicine coronary heart disease and plan to undergo PCI treatment; 2) Meet the differentiation standards of Qi stasis in Chinese medicine; 3) The age of the patient is = 18 and = 75 years old, and the gender is not limited; 4) The subject signs the informed consent form and participates voluntarily.

Exclusion criteria

Exclusion criteria: 1) Have a clear history of mental illness or substance abuse or severe cognitive impairment; 2) Are taking psychotropic drugs within a week; Must take anti-anxiety and depressant medications; 3) Have participated in or are participating in acupuncture treatment within one week; 4) Allergic constitution, such as history of allergy to acupuncture; 5) Serious adverse reactions of acupuncture; Skin infection at the site of needle; 6) Cerebrovascular sequelae limb paralysis, presence of other serious diseases, it is expected that three months of follow-up cannot be completed; 7) Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
TCM symptom score;

Secondary

MeasureTime frame
SAS/SDS;Seattle reviews angina scores;Visual analogue pain scoring;Quality of life scores;Sleep quality score;Cardiac function;blood lipids;blood sugar;Thyroid function;Levels of inflammatory factors;Cardiac ultrasound;electrocardiogram;

Countries

China

Contacts

Public ContactMin Fan

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine

2389985955@qq.com+86 133 7185 6187

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026